ucsf logo

David Tzou, MD

Urology
ucsf logo

David Tzou, MD

Urology
Urology Parnassus
415-353-2200

On this page

About me

Dr. David T. Tzou is a urologist who specializes in providing care for patients with complex kidney stone disease and men with urinary symptoms related to an enlarged prostate. He specializes in minimally invasive surgical treatments for these conditions and often cares for patients with medically complex or high-risk stone disease. He emphasizes clear communication and shared decision-making to help patients understand their condition and treatment options so they can make informed choices about their care.  

Tzou’s research focuses on better understanding why certain kidney stones are associated with infection, complex surgeries, as well as serious complications such as sepsis and prolonged recovery. His work aims to improve the safety of stone surgery by identifying infection risks earlier and developing strategies to reduce complications before, during and after treatment.

Tzou earned his medical degree from the University of Arizona College of Medicine, where he also completed a residency in urology. He completed a fellowship in endourology at UCSF. He is a member of the EDGE Research Consortium and the Kidney Stone Collaborative.

Education & training

Board certification

  • Urology, American Board of Urology

Fellowship

  • Endourology & Laparoscopy, University of CA at San Francisco - Urology GME

Residency

  • Urology, University of Arizona Hlth Sci Ctr - Urology

Internship

  • General Surgery, University of Arizona Hlth Sci Ctr-General Surgery

Degree

  • MD, University of Arizona College of Medicine

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.